Sinopharm has good profit growth prospect

Koon Yew Yin 17 July 2021

Since I have cashed out from the Malaysian stock market, I have been searching for stocks with good profit growth prospect to buy. I found Sinopharm which produce Sinovac vaccines. It is listed in the Hong Kong Stock Exchange. It is selling at PE 8. You can see Sinopharm price chart below.

This reminds me of my venture in the Hong Kong stock market in 1983. Let me tell you about the 2 opium wars.  

Short history of the 2 opium wars 

About 150 years ago, the British Government produced opium in India to sell to the Chinese. Many Chinese became opium addicts. 

In 1840, Britain went to war with China over questions of trade, diplomacy, national dignity and, most importantly, drug trafficking. While British officials tried to play down the illicit origins of the conflict, opponents gave it a name that made the link quite clear: the Opium War.

The war’s settlement forced Chinese ports open and gave Hong Kong to Britain. It began what China calls the “Century of Humiliation,” when foreign powers forced weak Chinese governments to cede territory and sign unequal treaties. Britain and France waged a second Opium War against China from 1856 to 1860. 

How I started to invest in the Hong Kong stock market.

In 1983 when China gave notice to the British Government to recover the sovereignty of Hong Kong, the Hong Kong stock market crashed. Hang Seng Index plunged below 1,000 points. 

During the Hong Kong stock market crash, I discovered a stock called Hong Realty and Trust (HKRT). The controlling shareholder was a Jew called Willock Marden. Just before the crash, the company sold Willock House. HKRT was selling at HK$ 13.60 before the crash and at HK$ 3.00 during the crash. It had more than HK$ 10 cash per share. 

As soon as China gave 50 years extension to the British Government, the stock market shot up like rocket. I could sell HKRT above HK$ 14.00 which I bought at HK$ 3 about 3 months ago.  

Within 3 years, I made so much money that I bought 46% of a stock broking company called Kaiser Stock and Share Co Ltd. 

Sinopharm reminds me of HKRT. Sinopharm produces Sinovac vaccines which is selling like hot cakes. Sinopharm will have fantastic profit growth prospect.